|
Artificial intelligence methods to predict chemotherapy-induced neutropenia in breast cancer patients. |
|
|
Employment - Decision Resources; Partners Healthcare; Precision Health AI |
Stock and Other Ownership Interests - Decision Resources |
Consulting or Advisory Role - Precision Health AI |
Patents, Royalties, Other Intellectual Property - Decision Resources; Harvard Medical School |
|
|
Employment - Precision Health AI |
Stock and Other Ownership Interests - Synageva Biopharma |
Consulting or Advisory Role - Decision Resources |
Research Funding - Precision Health AI |
Travel, Accommodations, Expenses - Precision Health AI |
|
|
Employment - Decision Resources (I); Precision Health AI (I); Synageva Biopharma (I) |
Leadership - Decision Resources (I); Precision Health AI (I); Synageva Biopharma (I) |
Stock and Other Ownership Interests - Decision Resources (I); Precision Health AI (I); Synageva Biopharma (I) |
Travel, Accommodations, Expenses - Decision Resources (I); Precision Health AI (I); Precision Health AI (I) |
|
|
No Relationships to Disclose |
|
|
Employment - Precision Health AI |
Travel, Accommodations, Expenses - Precision Health AI |
|
|
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst) |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Amgen (Inst); AstraZeneca (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst) |
|
|
Employment - Precision Health AI |
Leadership - Precision Health AI |
Stock and Other Ownership Interests - Precision Health AI; Transparency Life Sciences |
Consulting or Advisory Role - Transparency Life Sciences |
Research Funding - Precision Health AI |
|
|
No Relationships to Disclose |